Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | APAF1 | O14727 | 6/20 | 0.65 |
| ▸ | CASP3 | P42574 | 6/20 | 0.65 |
| ▸ | CASP9 | P55211 | 6/20 | 0.65 |
| ▸ | CYCS | P99999 | 6/20 | 0.65 |
| ▸ | SSTR5 | P35346 | 1/20 | 0.39 |
| ▸ | CCR5 | P51681 | 1/20 | 0.36 |
| ▸ | F2 | P00734 | 10/20 | 0.36 |
| ▸ | PRSS1 | P07477 | 9/20 | 0.36 |
| ▸ | ACHE | P22303 | 1/20 | 0.36 |
| ▸ | PRSS2 | P07478 | 1/20 | 0.34 |
| ▸ | PRSS3 | P35030 | 1/20 | 0.34 |
| ▸ | EPHX1 | P07099 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3701924 | 0.91 | APAF1 (0.78) | APAF1CASP3CASP9CYCSSSTR5 | |
| SCHEMBL5955953 | 0.84 | APAF1 (0.69) | APAF1CASP3CASP9CYCSCCR5 | |
| SCHEMBL3701083 | 0.84 | APAF1 (0.75) | APAF1CASP3CASP9CYCSCCR5 | |
| SCHEMBL12936634 | 0.81 | APAF1 (0.66) | APAF1CASP3CASP9CYCSCCR5 | |
| SCHEMBL3703370 | 0.80 | SSTR5 (0.44) | APAF1CASP3CASP9CYCSSSTR5 | |
| SCHEMBL9885477 | 0.80 | APAF1 (0.64) | APAF1CASP3CASP9CYCSCCR5 | |
| SCHEMBL3704146 | 0.79 | APAF1 (1.00) | APAF1CASP3CASP9CYCSCCR5 | |
| SCHEMBL9885474 | 0.79 | APAF1 (0.68) | APAF1CASP3CASP9CYCSCCR5 | |
| SCHEMBL3701840 | 0.77 | APAF1 (0.93) | APAF1CASP3CASP9CYCSCCR5 | |
| SCHEMBL3697511 | 0.77 | APAF1 (0.91) | APAF1CASP3CASP9CYCSCCR5 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9040701-B2 | Apaf-1 inhibitor compounds | LABORATORIOS SALVAT, S.A. (ES) | 2015-05-26 | — | — | US | disclosed |
| US-9040701-B2 | Apaf-1 inhibitor compounds | LABORATORIOS SALVAT, S.A. (ES) | 2015-05-26 | — | — | US | disclosed |
| US-9040701-B2 | Apaf-1 inhibitor compounds | LABORATORIOS SALVAT, S.A. (ES) | 2015-05-26 | — | — | US | disclosed |
| EP-2460798-A2 | APAF-1 INHIBITOR COMPOUNDS | Laboratorios SALVAT, S.A. (ES) | 2012-06-06 | — | — | EP | disclosed |
| US-20120122868-A1 | APAF-1 INHIBITOR COMPOUNDS | LABORATORIOS SALVAT, S.A. (ES) | 2012-05-17 | — | — | US | disclosed |
| US-20120122868-A1 | APAF-1 INHIBITOR COMPOUNDS | LABORATORIOS SALVAT, S.A. (ES) | 2012-05-17 | — | — | US | disclosed |
| US-20120122868-A1 | APAF-1 INHIBITOR COMPOUNDS | LABORATORIOS SALVAT, S.A. (ES) | 2012-05-17 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120122868-A1 | APAF-1 INHIBITOR COMPOUNDS | APAF1, API5, AIFM1 | APAF1 1/4885CASP3 13/4885CASP9 15/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.